510(k) Report

FDA applicant

Cagent Vascular, LLC

Wayne, PA5 decisions2017–20220 recalls

FDA records 5 decisions for Cagent Vascular, LLC (Wayne, PA) from 2017 to 2022: 5 510(k) clearances. All are in product code PNO (Catheter, Percutaneous, Cutting/Scoring). Since 2016 its 510(k)s took a median of 74 days from receipt to decision, against 94 for FDA’s reviews in the same codes and years. Its devices cite 5 predicates, 3 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Cagent Vascular, LLC’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2017: 12020: 22021: 12022: 1
2017high 2 (2020) · low 0 (2018)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2017.

FIG. 1 — Cagent Vascular, LLC by year, 2017–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Cagent Vascular, LLC’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report